The price of this share is at 26,98$, Myovant Sciences Ltd, with address at 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR, LONDON, SW1Y 4LB, United Kingdom, is a publicly traded company and its visible heads at the moment are David C. Marek (Chief Executive Officer & Director), Jeffrey D. Nornhold (Senior VP-Pharmaceutical Operations & Development), Juan Camilo Arjona Ferreira (Chief Medical Officer), Uneek Mehra (Chief Financial & Business Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United Kingdom.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 26,98$ - 27,00$, with a percentage difference of 26,99$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
